Evidence map›Paper›PMID 41945571›Full record

ArticlePloS one2026

Perceptions of factors influencing Ebola vaccine acceptance among community members, healthcare workers, and response personnel in Eastern Democratic Republic of the Congo.

Ruth Kallay, Pierre Muhoza, Dieula Delissaint Tchoualeu, Monica Fleming, Stephanie Garbern, Samuel Lwamushi Makali, Shiromi M Perera, Rigo Fraterne-Muhayangabo, Arsene Baleke Ombeni, Alexandra Tuttle and 5 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ruth KallayGlobal Immunization Division, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Pierre MuhozaGlobal Immunization Division, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0001-8344-1802
Dieula Delissaint TchoualeuGlobal Immunization Division, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Monica FlemingGlobal Immunization Division, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Stephanie GarbernWarren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.
Samuel Lwamushi MakaliRegional School of Public Health, Catholic University of Bukavu, Bukavu, Democratic Republic of Congo.
Shiromi M PereraInternational Medical Corps, Washington, DC, United States of America.ORCID https://orcid.org/0000-0002-9799-3568
Rigo Fraterne-MuhayangaboInternational Medical Corps, Goma, Democratic Republic of the Congo.
Arsene Baleke OmbeniInternational Medical Corps, Goma, Democratic Republic of the Congo.
Alexandra TuttleGlobal Immunization Division, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID https://orcid.org/0000-0001-8202-9402
Emma Aberle-GrasseGlobal Immunization Division, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Nancy OrtizGlobal Immunization Division, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Reena DoshiGlobal Immunization Division, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Adam C LevineWarren Alpert Medical School of Brown University, Providence, Rhode Island, United States of America.ORCID https://orcid.org/0000-0003-3982-3824
Eta Ngole MbongInternational Medical Corps, Goma, Democratic Republic of the Congo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe 2018-2020 Ebola Virus Disease (EVD) outbreak in Eastern Democratic Republic of the Congo (DRC) occurred amid armed conflict, institutional mistrust, and fragile health systems. The Ebola vaccine was deployed under emergency pre-licensure use, and concerns about it persisted. This study explored community and healthcare worker (HCW) perceptions of the Ebola vaccine to better understand the sociocultural and structural drivers of vaccine acceptance.

methodsWe conducted a qualitative study in three heavily affected health zones in North Kivu province (Beni, Butembo, and Mabalako) in 2021. Data were collected through thirty-three focus group discussions and 15 key informant interviews with EVD survivors, community members, HCWs, and local leaders, purposively sampled to capture diverse perspectives. Transcripts were analyzed using thematic and content analysis.

resultsParticipants reported concerns about the safety of the vaccine, mistrust in the institutions delivering it, and confusion due to rumors and inconsistent communication from the Ebola response. HCWs reported feeling coerced into vaccination rather than making a voluntary choice. Misinformation, logistical barriers, and perceptions of favoritism and stigmatization linked to ring vaccination were cited as preventing acceptance. Religion played a dual role, both fostering skepticism and encouraging acceptance depending on the stance of local faith leaders. Participants emphasized the need for transparent and balanced communication, equitable access, and greater involvement of trusted and competent community figures in vaccination efforts.

conclusionsEbola vaccine decision-making in Eastern DRC was shaped by complex interactions between institutional mistrust, perceived risk, religion, and access constraints within a broader context of sociopolitical instability. This study provides a critical baseline of perceptions during the vaccine's pre-licensure phase and highlights the importance of locally grounded engagement strategies. As vaccines become licensed, understanding local perceptions as well as leveraging the influence of trusted religious and community leaders will be essential for improving vaccine uptake.

Indexed as

Ebola VaccinesHealth PersonnelHemorrhagic Fever, EbolaPatient Acceptance of Health CareAdultDemocratic Republic of the CongoDisease OutbreaksEbolavirusFemaleFocus GroupsHumansMaleMiddle AgedTrustVaccinationEbola Vaccines

Identifiers

PMID41945571
PMCPMC13056191

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.